Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Competitors Push New Data In Coverage Battle For T-Wave Alternans Tests

This article was originally published in The Gray Sheet

Executive Summary

Industry and physician stakeholders say CMS missed a key study in considering its coverage policy for noninvasive tests that help assess a patient's need for an implantable defibrillator. Competing test makers have different views on how the new data should be interpreted
Advertisement

Related Content

CMS Considers Coverage For GE’s Risk-Predictor Tool For Sudden Cardiac Death
CMS Rejects Boston Scientific And GE Requests To Expand Coverage
CMS Rejects Boston Scientific And GE Requests To Expand Coverage
Medicare Coverage News In Brief
Medicare Coverage News In Brief
American Heart Association Meeting In Brief
Advertisement
UsernamePublicRestriction

Register

MT025907

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel